<DOC>
	<DOCNO>NCT03070938</DOCNO>
	<brief_summary>The PuraPly Antimicrobial Wound Matrix ( PuraPly AM ) case series prospective , observational study patient receive PuraPly AM consist collagen sheet coat polyhexamethylenbiguanide hydrochloride ( PHMB ) intend management wound ; experimental intervention involve .</brief_summary>
	<brief_title>PuraPlyâ„¢ Antimicrobial Wound Matrix Wound Management</brief_title>
	<detailed_description>The purpose case series ass ability PuraPly AM meet wound specific treatment goal include management bioburden , support granulation tissue formation support wind closure . Patients undergo clinical assessment receive standard care determine treat physician . The case series undertake good understand PuraPly AM utilization subsequent healing outcomes well evaluate effect concomitant wound therapy healing . Patient 's participation may involve follow-up 12 week follow application PuraPly AM .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>1 . Participant least 18 year age 2 . Participant read , understood sign Institutional Review Board ( IRB ) approve Informed Consent Form ( ICF ) . 3 . Participant least 1 wound appropriate receive PuraPly AM , include Partial fullthickness wound Pressure ulcer Venous ulcer Diabetic ulcer Chronic vascular ulcer Tunneled/undermined wound Surgical wound ( donor sites/grafts , postMohs ' surgery , postlaser surgery , podiatric , wound dehiscence ) h. Trauma wound ( abrasion , laceration , seconddegree burn , skin tear ) . Draining wound 1 . Participant known sensitivity porcine material 2 . Participant thirddegree burn 3 . Participant known sensitivity polyhexamethylenbiguanide hydrochloride ( PHMB ) 4 . Participants receive concurrent treatment topical antimicrobial skin substitute product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chronic wound</keyword>
	<keyword>Acute Wounds</keyword>
	<keyword>PHMB</keyword>
	<keyword>Wound Management</keyword>
	<keyword>Bioburden</keyword>
	<keyword>Collagen</keyword>
</DOC>